Physician profile
Carl D Hacker
NPI 1528588696
$25,760.70
in general payments reported to CMS, 2019-2025
8 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.07 · 2023: $222 · 2024: $25K · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $24,545.00 |
| Food and Beverage | $1,201.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20,041.67 | 2024-2025 | Activa PC, Intellis Adaptivestim |
| Abbott Laboratories | $5,104.64 | 2023-2025 | Eterna, Proclaim, Infinity |
| Biotronik Nro, INC. | $283.42 | 2024-2025 | Prospera |
| Boston Scientific Corporation | $116.39 | 2023-2025 | General - Dbs |
| Averitas Pharma INC. | $90.40 | 2024 | Qutenza |
| Livanova USA, INC. | $82.87 | 2025 | Vns Therapy Symmetry Model 8103 Generator |
| Integra Lifesciences Corporation | $27.24 | 2024 | Codman Certas, Cusa Clarity, Codman Hakim |
| Depuy Synthes Sales INC. | $14.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Hacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.